Previous attempts to treat Christine’s Chronic Lymphocytic Leukemia (CLL) had failed. She participated in a clinical trial and subsequently went through a CAR T-cell transplant at the NCI-designated Fred & Pamela Buffett Cancer Center.

The Fred & Pamela Buffett Cancer Center – Kearney is set to open in December 2024. It is a 53,000-square-foot facility that will offer comprehensive cancer care to patients in central Nebraska.

Missy Moser was first diagnosed with non-Hodgkin lymphoma in 2005 while she was pregnant with her son, Landon.

Watching his wife, Linda Grote, battle ovarian cancer was a painful experience, recalls Jimmy Grote Jr., of Minot, North Dakota. Sadly, Linda passed away just 18 months after her diagnosis. The nurses made such a big impression on Jimmy that he wanted to thank them by giving back.

Chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, is an innovative and promising treatment approach that has revolutionized the field of cancer therapy.

When Scott and Teresa Hueber celebrated their 40th wedding anniversary this past summer, it was much more than a celebration of marriage. It was also a celebration of life.

University of Nebraska Medical Center researchers are studying an experimental treatment for patients with specific subtypes of B-cell non-Hodgkin lymphomas. Potential candidates include patients who have undergone prior standard therapies that are no longer working or who have had cancer continue to return.

At age 67, Stephen Turkovich has no plans to slow down.

The partnership provides major benefits for patients in central Nebraska.

Battling cancer is no walk in the park, as Jeff Hockett, a five-year cancer survivor, can attest to. But sitting on the sideline watching a loved one endure cancer can often be equally as emotional and painful.